Amgen (AMGN) Copletes Mustafa Nevzat Pharma Acquisition
Amgen (Nasdaq: AMGN) announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company. The all-cash transaction significantly expands Amgen's presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FXCM, Inc. (FXCM) Board Adopts 'Poison Pill' Provision
- Amgen (AMGN) Announces Sumission of Kyprolis sNDA to FDA, MAA to EMA
- Pinnacle West Capital (PNW) Approached, Not Interested In Sale - TheDeal
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!